Stéphane Droupy

4PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBiologically active moleculesPacific Peoples social, cultural, emotional and spiritual wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 14, 2025
Safety and Efficacy of Neoadjuvant Durvalumab Plus Gemcitabine/Cisplatin or Carboplatin in Patients With Operable High-Risk Upper Tract Urothelial Carcinoma: The iNDUCT-GETUG V08 Trial.

Nadine Houédé, Thierry Chevallier, François Audenet

|Jan 17, 2023
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).

Astrid Boulenger de Hauteclocque, Loïc Ferrer, Damien Ambrosetti

|Jun 13, 2022
Assessment of a New Formulation of Sildenafil on Common Practice: An Observational Study.

Stéphane Droupy, Marie Hélène Colson

|Apr 27, 2022
EQUINOXE study: Impact of relational cohesion and sexuality on the quality of life of patients treated with gonadotropin-releasing hormone agonist for prostate cancer.

Stéphane Droupy, Marie-Hélène Colson, Nathalie Pello-Leprince-Ringuet

Pageof 1

Frequent Collaborators

1 joint publications

Astrid Boulenger de Hauteclocque

1 joint publications

Damien Ambrosetti

1 joint publications

Franck Bruyère

1 joint publications

Cédric Lebâcle